Coordinatore | SOCIEDAD PARA EL FOMENTO DE LA INNOVACION TECNOLOGICA S.L. - INNOVATEC
Organization address
address: RONDA DE VALDECARRIZO 41B contact info |
Nazionalità Coordinatore | Spain [ES] |
Totale costo | 3˙479˙337 € |
EC contributo | 2˙859˙568 € |
Programma | FP7-HEALTH
Specific Programme "Cooperation": Health |
Code Call | FP7-HEALTH-2010-single-stage |
Funding Scheme | CP-FP-SICA |
Anno di inizio | 2011 |
Periodo (anno-mese-giorno) | 2011-01-01 - 2014-10-31 |
# | ||||
---|---|---|---|---|
1 |
SOCIEDAD PARA EL FOMENTO DE LA INNOVACION TECNOLOGICA S.L. - INNOVATEC
Organization address
address: RONDA DE VALDECARRIZO 41B contact info |
ES (TRES CANTOS) | coordinator | 941˙040.00 |
2 |
UNIVERSITY OF LEEDS
Organization address
address: WOODHOUSE LANE contact info |
UK (LEEDS) | participant | 449˙998.00 |
3 |
HET KONINKLIJK INSTITUUT VOOR DE TROPEN
Organization address
address: "Mauritskade, 63" contact info |
NL (AMSTERDAM) | participant | 356˙400.00 |
4 |
UNION AFRICANE
Organization address
address: Rue Roosevelt (Old Airport Area) s/n contact info |
ET (ADDIS ABABA) | participant | 320˙400.00 |
5 |
MAHIDOL UNIVERSITY
Organization address
address: RATCHAWITHI ROAD 420/6 contact info |
TH (BANGKOK) | participant | 240˙224.00 |
6 |
INSTITUTO DE HIGIENE E MEDICINA TROPICAL
Organization address
address: Rua da Junqueira 100 contact info |
PT (LISBOA) | participant | 188˙785.60 |
7 |
COLEGIO MAYOR DE NUESTRA SENORA DEL ROSARIO
Organization address
address: CALLE 12C 6-25 contact info |
CO (BOGOTA) | participant | 143˙421.00 |
8 |
Association for Stimulating Know How
Organization address
address: DLF - Phase III V - 30/3 contact info |
IN (Gurgaon - Haryana) | participant | 132˙000.00 |
9 |
College of Medicine of the University of Nigeria
Organization address
address: Old University of Nigeria Teaching Hospital Road Ogbete contact info |
NG (Enugu) | participant | 87˙300.00 |
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
'EVAL-HEALTH is an R&D project which has as its main goal to contribute to strengthen monitoring and evaluation of European Union (EU) funded interventions in developing countries in the specific area of Health, The major objectives of EVAL-HEALTH are: 1) To develop a sound methodological approach to evaluate and monitor implementation and performance of EU funded interventions in developing countries in the health sector by: i) Identifying best practices in M&E aid and their impact on health issues from major international donors and agencies active in the field. ii) obtaining comprehensive insight of the EC funded bilateral interventions in health sector. iii) Developing specific methodological models and tools for M&E of the impact of EU funded bilateral interventions (sector/budget support, Individual projects, R&D actions) iv) Testing on the field the suitability and applicability of the developed methodologies through case studies methodology. 2) To understand how the developed tools and methodologies adapts to different EU interventions. 3) To disseminate the results obtained in the project to the main project stakeholders as a means to increase and improve European funded interventions effectiveness in the health sector. EVAL-HEALTH is planned as a 46 month R&D project, with 9 participants from Spain, UK, the Netherlands Portugal, South Africa, Nigeria, Thailand, India and Colombia.The consortium will benefit from the inclusion of three high-level external Advisory Committees (Donors, Recipients and Scientific). These committees will be formed by relevant experts on M&E health aid in developing countries and will provide an important accumulated expertise to the project. As results of the EVAL-HEALTH project, EC Services and development partner countries will have improved methodologies specifically developed for health aid to strengthen M&E of EU funded interventions.'
An EU-funded project developing a new methodology to identify and assess research impact. Research project analysing the role of different types of evidence in health policy in low and middle-income countries (India and Nigeria).
The project http://www.eval-health.eu/ (EVAL-HEALTH) has developed a methodology to monitor and assess the impacts of international public health research projects funded by the European Commission. This Methodology has been named Impact Oriented Monitoring (IOM), as it tries to anticipate as much as possible the impact of projects during the monitoring process.
The methodology can support EC officers in the identification, recording and assessment of individual project results and impacts, and can be used to monitor how the project is performing, identifying results and evidence to anticipate project impacts. It can also be used to assess the final results and provide an estimation of the type of impacts of individual projects in terms of Knowledge production, capacity building and research targeting, policy and decision making and health and health sector benefits. The methodology can also help future programme evaluations. For the development of the methodology, the project has worked with public health research projects funded by the 5FP and 6FP with participation of low and middle income countries. Nine case studies have been carried out in Africa, Latina America and Asia to further analyse the usefulness of the methodology and the designed tools for data collection.
The project has also worked towards gaining better understanding of the role of evidence in health policy and strategy development, as well as the perception of evidence by different policy actors. Research has been conducted in India and Nigeria. In each of the two countries three specific policies were selected to examine the role of evidence. In India, the policies were: National AIDS Control Programme (NACP III); National Tobacco Control Programme 2007 (NTCP); and the Accredited Social Health Activists programme of 2005 (ASHA). In Nigeria, the policies were: Integrated Maternal, Neonatal and Child Health strategy 2007 (IMNCH); Human Resources for Health Policy 2006 (HRH) and Oral Health Policy 2012 (OHP).
Project results showed that there were two different understandings of evidence among policy actors in the two countries. Some policy actors regarded evidence only as factual, concrete and verifiable data used for decision making while others defined evidence more broadly as including both stakeholder experiences and systematically generated data such as published research, monitoring & evaluation and other reports documenting best practices or programme effectiveness. The analysis has also revealed that all health policies and strategies studied are perceived by the policy actors to be evidence-informed. Five broad types of evidence informed policy development in the study countries: policies and regulatory evidence, routine programme and survey data, research findings, situation analysis commissioned for policy and views and experiences of stakeholders.
Understanding inflammation-associated tumorigenesis for the rational design of novel anti-cancer therapeutic strategies
Read More